New medication given every one to three months may slash stubborn high cholesterol
A new PCSK9 inhibitor (recaticimab) injected every one to three months may work safely and provide more flexible dosing to lower cholesterol, according to late-breaking science presented today at the American Heart Association's ...
Nov 13, 2023
0
0